Author:
Zhang Honglian,Chen Si,Li Jing,Yang Huan,Luo Yue-Bei
Funder
the Jiangxi Provincial Health Commission science and technology plan
the Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Khurana A, Novo M, Nowakowski GS, Ristow KM, Spinner RJ, Hunt CH, et al. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the Rituximab era. Blood Adv. 2021;5:1379–87.
2. Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neurooncology. 2010;12:212–5.
3. Stübgen JP. Lymphoma-associated dysimmune polyneuropathies. J Neurol Sci. 2015;355:25–36.
4. Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J (Sudbury Mass). 2012;18:463–8.
5. Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115:5005–11.